HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Choi, H. K. Articles by Kang, K. W. Search for Related Content PubMed PubMed Citation Articles by Choi, H. K. Articles by Kang, K. W.

BK21 Project Team, College of Pharmacy, Chosun University, Gwangju 501-759, South Korea

(Correspondence should be addressed to K W Kang; Email: kwkang{at}chosun.ac.kr; H G Jeong; Email: hgjeong{at}chosun.ac.kr)

Both the functional loss of p53 and the overexpression of aromatase are important for the progression of breast cancer in postmenopausal women. Here, we found that aromatase expression was up-regulated in primary cultures of mammary epithelial cells (p53^5,6 MEC) isolated from mice with a defect in exons 5 and 6 of the p53 gene. Aromatase basal activity and expression levels were significantly increased in p53^5,6 MEC when compared with wild-type MEC. Reporter gene activity in p53^5,6 MEC transfected with the aromatase promoter or the cAMP-responsive element (CRE) minimal promoter was higher than wild-type MEC. p53 inactivation increased both Ser133-phosphorylated CRE-binding protein (CREB) and the nuclear accumulation of CREB. Inhibition of extracellular signal-regulated kinase (ERK) or Src tyrosine kinase blocked aromatase gene transactivation and CREB activation in the p53^5,6 MEC. These results support the hypothesis that a genetic defect in the function of p53 enhances the expression of aromatase via ERK or Src activation in MEC, which suggests that aromatase expression is closely related to the p53 status in MEC.

This article has been cited by other articles:

				A. P. B. Batschauer, C. P. Figueiredo, E. C. Bueno, M. A. Ribeiro, L. M. S. Dusse, A. P. Fernandes, K. B. Gomes, and M. G. Carvalho D-dimer as a possible prognostic marker of operable hormone receptor-negative breast cancer Ann. Onc., October 30, 2009; (2009) mdp474v1. [Abstract] [Full Text] [PDF]